Bioage Labs, INC. (BIOA) — 10-K Filings
All 10-K filings from Bioage Labs, INC.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
BioAge's BGE-102 Shows Strong CV Risk Reduction in Phase 1 Data
— Mar 24, 2026 Risk: high
BioAge Labs, Inc. (BIOA) is a clinical-stage biopharmaceutical company focused on developing therapies for metabolic diseases by targeting human aging biology. - 10-K Filing — Mar 20, 2025
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX